Correlation between metal ions and clinical findings in subjects affected by Alzheimer's disease.

There is a growing interest to evaluate metals in biological fluids in Alzheimer's disease (AD). There are numerous studies on this theme, but just few papers analyzed the relationship between haematic metal concentrations and the clinical features of the disease. In this study, possible associations between clinical features of AD and the variations in serum and blood concentration of some metals, as well as the serum oxidative status and the antioxidant capacity have been investigated. Sixty subjects with AD were enrolled. Some elements correlated with gender, depression and duration of the disease. However, the most significant result was the relationship between blood Ca and Fe levels and the severity of cognitive impairment. We hypothesize that Ca and Fe might play an important role in the pathogenetic mechanisms of AD.

[1]  B Carragher,et al.  Three-Dimensional Analysis of the Relationship Between Synaptic Pathology and Neuropil Threads in Alzheimer Disease , 1992, Journal of neuropathology and experimental neurology.

[2]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[3]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[4]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[5]  Xudong Huang,et al.  Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology , 2004, Annals of the New York Academy of Sciences.

[6]  S. Brenner.  Elevation of serum copper levels in Alzheimer’s disease , 2003, Neurology.

[7]  E Magni,et al.  Mini‐Mental State Examination: a normative study in Italian elderly population , 1996, European journal of neurology.

[8]  D. Selkoe,et al.  The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease. , 1992, Alzheimer disease and associated disorders.

[9]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[10]  A. Bush.  Copper, zinc, and the metallobiology of Alzheimer disease. , 2003, Alzheimer disease and associated disorders.

[11]  G. Perry,et al.  The role of metals in neurodegenerative diseases. , 2000, Cellular and molecular biology.

[12]  A. Nunomura,et al.  Oxidative Stress, Antioxidants, and Alzheimer Disease , 2000, Alzheimer disease and associated disorders.

[13]  D. Selkoe.  Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer's disease. , 1996, Cold Spring Harbor symposia on quantitative biology.

[14]  Xudong Huang,et al.  Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.

[15]  B. Bocca,et al.  Development of methods for the quantification of essential and toxic elements in human biomonitoring. , 2005, Annali dell'Istituto Superiore di Sanità.

[16]  C. Höschl,et al.  Alterations in calcium homeostasis as biological marker for mild Alzheimer's disease? , 2004, Physiological research.

[17]  P. Stanzione,et al.  Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson’s disease , 2004, Journal of Neural Transmission.

[18]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[19]  C. Behl.  Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. , 1997, Cell and tissue research.

[20]  R. Tanzi,et al.  Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. , 1999, Metal ions in biological systems.

[21]  Ashley I. Bush,et al.  The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.

[22]  D. Selkoe,et al.  The Seminal Role of β‐Amyloid in the Pathogenesis of Alzheimer Disease , 1992 .

[23]  C. Masters,et al.  A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. , 1993, The Journal of biological chemistry.

[24]  Jae-Young Koh,et al.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[26]  R. Tanzi,et al.  Modulation of A beta adhesiveness and secretase site cleavage by zinc. , 1994, The Journal of biological chemistry.

[27]  A. Korten,et al.  The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.

[28]  A. Barnea,et al.  Evidence for release of copper in the brain: Depolarization‐induced release of newly taken‐up 67copper , 1988, Synapse.

[29]  Carsten Schmidt,et al.  Evidence for a copper-binding superfamily of the amyloid precursor protein. , 2002, Biochemistry.

[30]  B. Bocca,et al.  High-throughput microwave-digestion procedures to monitor neurotoxic elements in body fluids by means of inductively coupled plasma mass spectrometry , 2003, Analytical and bioanalytical chemistry.

[31]  Y. Christen,et al.  Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.

[32]  A. Bush,et al.  Specific metal-catalysed protein oxidation reactions in chronic degenerative disorders of ageing: focus on Alzheimer's disease and age-related cataracts. , 2001, Novartis Foundation symposium.

[33]  D. Harman,et al.  Free radical theory of aging: Alzheimer’s disease pathogenesis , 1995, AGE.

[34]  Xudong Huang,et al.  Metal Chelation as a Potential Therapy for Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[35]  C. Masters,et al.  Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice , 1999, Brain Research.

[36]  A. Pascale,et al.  Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities. , 1999, Pharmacological research.

[37]  J. Connor,et al.  Abnormal localization of iron regulatory protein in Alzheimer's disease , 1998, Brain Research.

[38]  G. Perry,et al.  Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. , 2000, Antioxidants & redox signaling.

[39]  M. Luca,et al.  Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome. , 1996, Archives of neurology.